Genotropin: profile and news

Pfizer's Latest Growing Pains Mar 5, 2006
...internal documents that shed new light on allegations that Pharmacia, a company Pfizer acquired in 2003, improperly promoted its drug Genotropin to doctors who ... - BusinessWeek

Big money, big fines - it's all hormonal Feb 23, 2006
A one-month course of treatment can cost US$1,000, says Dr. Peter Rost, who formerly oversaw the marketing of Genotropin, Pfizer Inc.'s brand of growth hormone ... - Macleans,

'Biosimilars' target a market of $50bn Feb 17, 2006
...the agency has agreed that copycat growth hormone Omnitrope, produced by Novartis subsidiary Sandoz, had the same safety and efficacy of Genotropin, the Pfizer ... - MSN Money

Door opens for cheap copies of biotechnology drugs Feb 7, 2006
...the European Commission, agreed that Omnitrope, a growth hormone produced by Sandoz, had shown similar quality and efficacy to that of Genotropin, the original ... - Legalbrief (subscription),

Novartis lining up further copycat biotech drugs Feb 6, 2006
Omnitrope, a copycat version of Pfizer's growth hormone Genotropin which received a positive opinion from an EU panel last month, has been seen as the poster ... - Reuters

Pfizer Driving Performance Through Growth of Current and New ... Feb 10, 2006
...scope of Pfizer's R&D activities, Dr. LaMattina said the company has established a firm foothold in biologics with medicines including Genotropin and Macugen ... - MSN Money

Novartis lining up further copycat biotech drugs Feb 6, 2006
Omnitrope, a copycat version of Pfizer's growth hormone Genotropin which received a positive opinion from a European Union panel last month, has been seen as ... - CNET News.com,

Manhattan Pharmaceuticals Names Alan Harris Chief Medical Officer Feb 1, 2006
...(New York, NY) where he oversaw the clinical development of the growth hormone Genotropin(r), the growth hormone antagonist Somavert(r), and the leading ... - PharmaLive.com (press release),

EU agency backs generic growth hormone Jan 27, 2006
Omnitrope, a growth hormone made by Sandoz, the generic arm of Novartis, showed comparable quality, safety and efficacy to the Pfizer drug Genotropin, which is ... - International Herald Tribune,

EMEA - Committee For Medicinal Products For Human Use - 23-26 ... Jan 29, 2006
...children and adults. Omnitrope is similar to Genotropin, the reference medicinal product already authorised in the EU. A separate ... - Medical News Today (press release),

Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect ... Jan 19, 2006
362 353 2 116 123 (5) 246 230 7 XALATAN/ XALACOM 361 353 2 116 123 (5) 245 230 7 - ENDOCRINE DISORDERS 266 257 4 86 84 3 180 173 4 GENOTROPIN 204 200 2 60 57 7 ... - PR Newswire (press release),

European Regulator Recommends Generic Copy of Biotech Drug Jan 27, 2006
...that studies on Omnitrope, a growth hormone made by Sandoz, the generic arm of Novartis, showed comparable quality, safety and efficacy to Genotropin, a Pfizer ... - New York Times,

Ex-Pfizer VP named 2005's "Whiny Whistleblower" Jan 10, 2006
Dr. Eric Topol, the Cleveland Clinic," Rost said, adding "I’m only saddened that Dr. Ross failed to mention that under my leadership Genotropin became the #1 ... - Spero News

Pfizer Finally Boots Longtime Critic Dec 2, 2005
The statement also said that he believed Pfizer had been the subject of a criminal investigation by the Boston US Attorney's office into the drug Genotropin. ... - Brandweek Magazine,

Pfizer Fires a Vice President Who Criticized the Company's Sales ... Dec 1, 2005
Mr. Rost contends that Pharmacia offered doctors illegal inducements to use genotropin, its growth hormone, as an anti-aging drug for adults. ... - New York Times,

Pfizer Seeks to Oust Outspoken Executive Dec 1, 2005
...filed in June 2003, Rost alleged that Pharmacia, which was acquired by Pfizer two months earlier, marketed the human growth hormone Genotropin "off-label," or ... - Forbes

Pfizer accused of firing exec in retaliation Dec 2, 2005
Documents unsealed earlier this week showed Rost in June 2003 filed a lawsuit alleging the illegal promotion of Genotropin, a human growth hormone. ... - Reuters

Pfizer fires industry critic, a whistle-blower Dec 1, 2005
The lawsuit against Pharmacia and Pfizer, filed under seal since June 3, 2003, claimed Genotropin, a human growth hormone, was illegally promoted for off-label ... - Newark Star Ledger,

Pfizer Fires Executive Rost, Cites Federal Government's Decision ... Dec 2, 2005
Silverman, Newark Star-Ledger , 12/2). Rost's lawsuit alleged that Pharmacia engaged in inappropriate sales and marketing of the growth hormone Genotropin. ... - Kaiser network.org,

Pfizer Fires Exec in Whistleblower Suit Dec 2, 2005
...that he raised.". The government is currently investigating the Genotropin allegations in a separate criminal case. Fitzhenry said ... - Herald News Daily,

Pfizer fires whistle-blower vice-president Dec 2, 2005
Rost contends that Pharmacia offered doctors illegal inducements to use genotropin, its growth hormone, as an anti-aging drug for adults. ... - Indian Express,

Business notebook Dec 2, 2005
Rost charged in 2003 that Pharmacia, a Pfizer unit, marketed the human growth hormone Genotropin for unapproved uses and improperly sought reimbursement from ... - Boston Globe,

Business briefs Dec 3, 2005
Rost, vice president of marketing, charged in a 2003 complaint that Pharmacia, a Pfizer subsidiary, marketed the human growth hormone Genotropin for unapproved ... - NorthJersey.com,

Lawsuit brought over generic-biotech issue:- Sep 14, 2005
Drug manufacturer Pfizer Inc. has petitioned the FDA to reject Omnitrope, which is the Sandoz generic version of Pfizer's Genotropin. ... - Webindia123,

Medical advances help 3-year-old face challenges Oct 5, 2005
To combat some of the various medical concerns associated with the disease, a recombinant human growth hormone known as Genotropin was made commercially ... - Asbury Park Press,

Novartis Stays Focused Sep 20, 2005
...biologic drugs. Novartis claims Omnitrope is indistinguishable from Pfizer's (NYSE: PFE) human growth hormone Genotropin. As the ... - Motley Fool

Sandoz takes issue with FDA over biogenerics Sep 15, 2005
...informed Sandoz that Omnitrope was safe and effective for its intended use and that it was indistinguishable from the originator product, Pfizer's Genotropin. ... - in-PharmaTechnologist,

Pfizer Inc Second-Quarter 2005 Performance Report Jul 20, 2005
A supplemental US filing was submitted in June for the use of Genotropin, the world's leading human recombinant growth hormone, in the treatment of short ... - Yahoo News (press release) <**results**>

Lonely life of a whistleblower Jun 12, 2005
...where Dr Rost formerly worked. At the time, he ran the marketing of the growth hormone genotropin. Mr Fitzgerald described Dr Rost's ... - Sydney Morning Herald (subscription)

Critic of drug prices isolated at Pfizer Inc. Jun 12, 2005
...worked. At the time of that acquisition, Rost supervised Pharmacia's marketing of a growth hormone called genotropin. Fitzgerald ... - Akron Beacon Journal

Marketing Exec Feels Heat At Pfizer Jun 7, 2005
...doing great, we're 20 % ahead of budget" this year. His main brand is Genotropin, a hormone for children whose growth is stunted. - Brandweek Magazine,

Report: Critic isolated at Pfizer Jun 8, 2005
...most recent annual report, Pfizer disclosed that in late 2003 the Justice Department had opened an investigation into its marketing of genotropin, the growth ... - CNN

500 jobs to go as Pfizer closes Stockholm factory Jun 8, 2005
..."To have to shut down development of the product is a great disappointment for all of us.". The product in question is the growth hormone, Genotropin. ... - The Local,

PHARMA: Is Pfizer's Black Knight on the way out? Jun 8, 2005
...currently, as according to the Times "Pfizer disclosed that the Justice Department had opened an investigation into its marketing of genotropin, the growth ... - Health Care Blog

A Day in the Life of Peter Rost Jun 8, 2005
Rost has escaped that fate, apparently, because Pfizer's marketing of the growth hormone genotropin is under investigation, and Rost was in charge of that at ... - Corante